The RAPSN gene fetal akinesia deformation sequence genetic test is a specialized diagnostic procedure aimed at identifying mutations in the RAPSN gene, which are linked to the development of fetal akinesia deformation sequence (FADS). FADS is a rare genetic disorder characterized by reduced fetal movement (akinesia), which can lead to a range of physical deformities and developmental issues in newborns, including joint contractures, facial anomalies, and lung hypoplasia. The RAPSN gene plays a crucial role in the development and function of the neuromuscular junction, and mutations in this gene can disrupt normal muscle movement and growth.
Performed at DNA Labs UAE, this test is an important tool for expecting parents with a family history of neuromuscular disorders or for cases where fetal akinesia or related deformities are suspected during pregnancy. Early and accurate diagnosis through this test can aid in the management of the condition and in making informed decisions regarding the pregnancy.
The cost of the RAPSN gene fetal akinesia deformation sequence genetic test at DNA Labs UAE is 4400 AED. This investment includes the collection of a sample, typically through amniocentesis or chorionic villus sampling, and comprehensive genetic analysis to detect any mutations in the RAPSN gene. Given the complexity and specificity of the test, it represents a critical step towards understanding the genetic underpinnings of FADS and facilitating better outcomes for affected families.
The COL11A1 gene plays a critical role in the development of connective tissues in the body, particularly in the formation of collagen type XI, which is essential for the proper development of bones and cartilage. Mutations in the COL11A1 gene can lead to a rare genetic disorder known as Fibrochondrogenesis Type 1. This condition is characterized by short stature, a narrow chest, short limbs, and other skeletal abnormalities that can significantly impact an individual's quality of life.
To diagnose this condition, a genetic test targeting the COL11A1 gene can be conducted. This test involves analyzing the DNA to identify mutations in the COL11A1 gene that are responsible for Fibrochondrogenesis Type 1. Early diagnosis through genetic testing is crucial for the management of the condition, allowing for appropriate medical interventions and genetic counseling for affected families.
In the UAE, DNA Labs offers this specialized genetic test for Fibrochondrogenesis Type 1. The test is priced at 4400 AED, reflecting the comprehensive analysis and detailed report provided by the lab. Conducting this test at DNA Labs UAE ensures that individuals and families receive accurate and reliable results, aiding in the diagnosis and understanding of Fibrochondrogenesis Type 1, and facilitating informed decisions regarding treatment and management options.
The DISP1 Gene Craniofacial and Neuro-Developmental Abnormalities Genetic Test is a specialized diagnostic tool offered by DNA Labs UAE, designed to identify mutations in the DISP1 gene, which are associated with various craniofacial and neuro-developmental disorders. This test is crucial for early detection and management of conditions that can affect the development of the face and skull, as well as the brain and nervous system, leading to a range of physical and cognitive challenges. Priced at 4400 AED, this test provides families and healthcare providers with essential genetic information that can guide treatment plans, interventions, and supportive care, ultimately improving the quality of life for affected individuals. By leveraging advanced genetic testing technologies, DNA Labs UAE ensures accurate and reliable results, making the DISP1 Gene Test a valuable resource for those at risk of these complex disorders.
The JAG2 gene plays a significant role in the development of craniofacial structures and the nervous system. Mutations in this gene can lead to various craniofacial and neuro-developmental abnormalities, impacting an individual's appearance, brain function, and overall health. Recognizing the importance of early diagnosis and intervention, DNA Labs UAE offers a specialized genetic test to identify mutations in the JAG2 gene.
This test is crucial for individuals with a family history of craniofacial or neuro-developmental disorders, as well as for those exhibiting related symptoms without a known cause. By analyzing the JAG2 gene, the test can confirm a diagnosis, guide treatment options, and provide essential information for family planning.
The cost of the JAG2-related genetic test at DNA Labs UAE is 4400 AED. This investment covers the comprehensive analysis required to detect any mutations in the JAG2 gene, providing patients and their families with valuable insights into their genetic health. With this information, healthcare providers can tailor interventions more effectively, potentially improving outcomes for those affected by related abnormalities.
The VSX1 Gene Craniofacial Anomalies and Anterior Segment Dysgenesis Syndrome Genetic Test is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the VSX1 gene. These mutations are associated with a range of conditions, including craniofacial anomalies and anterior segment dysgenesis syndrome, which can lead to significant visual impairment. The test is crucial for individuals exhibiting symptoms of these conditions or those with a family history, as it provides essential information for accurate diagnosis, management, and treatment planning.
Performed in the state-of-the-art facilities of DNA Labs UAE, the test ensures high accuracy and reliability. The cost of the test is 4400 AED, which reflects the sophisticated technology and expertise required to analyze genetic variations accurately. By opting for this genetic test, patients and healthcare providers can make informed decisions regarding the care and intervention strategies to manage or mitigate the impact of these genetic disorders.
The EFNB1 Gene Craniofrontonasal Syndrome Genetic Test is a specialized diagnostic assessment offered by DNA Labs UAE, aimed at identifying mutations in the EFNB1 gene, which are linked to Craniofrontonasal Syndrome (CFNS). CFNS is a rare genetic disorder characterized by distinctive craniofacial, skeletal, and dermatological abnormalities, often manifesting differently between males and females due to its X-linked inheritance pattern. The condition is primarily caused by mutations in the EFNB1 gene, which plays a crucial role in cell signaling and tissue development during embryonic growth.
This genetic test is crucial for families with a history of CFNS, offering them an opportunity for early diagnosis, which is essential for the management and treatment of the condition. The process involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed in the laboratory for any abnormalities in the EFNB1 gene.
At DNA Labs UAE, the EFNB1 Gene Craniofrontonasal Syndrome Genetic Test is available for 4,400 AED. The test is conducted with a high level of accuracy and confidentiality, ensuring that individuals and families receive precise information about their genetic health. Results from this test can guide healthcare professionals in creating a tailored management plan for those affected by CFNS, potentially improving their quality of life and mitigating some of the condition's more severe manifestations.
Craniometaphyseal Dysplasia (CMD) is a rare genetic disorder characterized by abnormal bone growth in the skull and jaw, leading to distinctive facial features and dental abnormalities. The condition is caused by mutations in the ANKH gene, which plays a crucial role in bone development and mineralization. Identifying the specific genetic mutation responsible for CMD can provide valuable information for diagnosis, management, and genetic counseling of affected individuals and their families.
DNA Labs UAE offers a specialized genetic test targeting the ANKH gene to identify mutations associated with Craniometaphyseal Dysplasia. This test is pivotal for individuals showing symptoms of CMD or those with a family history of the disorder, providing a definitive diagnosis and facilitating appropriate medical interventions.
The cost of the ANKH Gene Craniometaphyseal Dysplasia Genetic Test at DNA Labs UAE is 4400 AED. Conducted in a state-of-the-art laboratory by experienced geneticists, the test offers a high degree of accuracy and reliability. Results from the test can help guide treatment plans and inform patients about the likelihood of passing the condition on to their offspring, thus playing a crucial role in the management of CMD.
The IL11RA Gene Craniosynostosis and Dental Anomalies Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE, designed to identify mutations in the IL11RA gene that are associated with craniosynostosis and dental anomalies. Craniosynostosis is a condition characterized by the premature fusion of one or more cranial sutures, leading to abnormal skull shape and potentially affecting brain development. Dental anomalies may include a range of issues from abnormal tooth size, shape, or number to misalignment of the teeth and jaws.
This test is crucial for individuals displaying symptoms of these conditions or those with a family history, as it aids in confirming the diagnosis, understanding the risk of recurrence in families, and guiding treatment plans. Conducted through a sample of blood or saliva, the analysis focuses on detecting specific genetic mutations in the IL11RA gene that have been linked to these developmental issues.
The cost of the IL11RA Gene Craniosynostosis and Dental Anomalies Genetic Test at DNA Labs UAE is set at 4400 AED. This investment covers the comprehensive genetic analysis and the professional interpretation of results, providing essential insights for affected individuals and their families. Early detection and diagnosis through this test can significantly impact the management and outcome of these conditions, emphasizing its value in personalized medicine and genetic counseling.
The TWIST1 gene craniosynostosis type 1 genetic test is a specialized diagnostic procedure offered by DNA Labs UAE, designed to detect mutations in the TWIST1 gene, which are known to cause craniosynostosis type 1. This condition is characterized by the premature fusion of certain skull bones, leading to an abnormal head shape and potentially affecting brain development. The test is crucial for early diagnosis and management of the condition, ensuring affected individuals receive appropriate medical and surgical interventions. The cost of the test is 4400 AED, reflecting the sophisticated technology and expertise required to accurately identify mutations in the TWIST1 gene. By opting for this test at DNA Labs UAE, patients and their families can access reliable and critical genetic information that can guide clinical decisions and personalized care plans for those affected by craniosynostosis type 1.
The MSX2 gene craniosynostosis type 2 genetic test is a specialized diagnostic tool designed to identify mutations in the MSX2 gene, which are associated with the development of craniosynostosis type 2, a rare genetic disorder. This condition is characterized by the premature fusion of certain skull bones, leading to abnormal head shape and potentially causing pressure on the brain with developmental issues. The test is crucial for early detection, allowing for timely intervention and management of the condition to mitigate complications.
Performed at DNA Labs UAE, a leading facility in genetic testing, the test involves collecting a DNA sample, typically through a blood draw or cheek swab, and analyzing it for specific genetic mutations in the MSX2 gene. The cost of the test is 4400 AED, reflecting the comprehensive analysis and expertise required to accurately diagnose this condition. By identifying the presence of these genetic mutations, healthcare providers can better understand the condition's progression, tailor treatments to the individual's needs, and offer genetic counseling to affected families.
